Search

Your search keyword '"Ouchen Wang"' showing total 102 results

Search Constraints

Start Over You searched for: Author "Ouchen Wang" Remove constraint Author: "Ouchen Wang"
102 results on '"Ouchen Wang"'

Search Results

1. The PDE4DIP-AKAP9 axis promotes lung cancer growth through modulation of PKA signalling

2. Mechanisms underlying neutrophils adhesion to triple-negative breast cancer cells via CD11b-ICAM1 in promoting breast cancer progression

Catalog

Books, media, physical & digital resources

3. PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the NF1/RAS signaling axis

4. P110α inhibitor alpelisib exhibits a synergistic effect with pyrotinib and reverses pyrotinib resistant in HER2+ breast cancer

5. RecurIndex assay as an aid for adjuvant chemotherapy decisions in HR-positive HER2-negative breast cancer patients

6. Pan-cancer analysis of the prognostic and immunological role of PSMB8

7. Pyrotinib-Containing Neoadjuvant Therapy in Patients With HER2-Positive Breast Cancer: A Multicenter Retrospective Analysis

8. Osthole inhibits triple negative breast cancer cells by suppressing STAT3

9. Knockdown of LncRNA MAPT-AS1 inhibites proliferation and migration and sensitizes cancer cells to paclitaxel by regulating MAPT expression in ER-negative breast cancers

10. Anticancer activity of 2α, 3α, 19β, 23β-Tetrahydroxyurs-12-en-28-oic acid (THA), a novel triterpenoid isolated from Sinojackia sarcocarpa.

11. Abstract OT2-14-01: Pyrotinib after trastuzumab-based adjuvant therapy in high-risk early human epidermal growth factor receptor 2-positive breast cancer: a multicenter phase 2 trial

12. LINC00891 promotes tumorigenesis and metastasis of thyroid cancer by regulating SMAD2/3 via EZH2

14. Serine Protease 27, a Prognostic Biomarker in Pan-cancer and Associated with the Aggressive Progression of Breast Cancer

15. Radiomics-based signature of breast cancer on preoperative contrast-enhanced MRI to predict axillary metastasis

16. Pannexin 1 Mediates Gastric Cancer Cell Epithelial–Mesenchymal Transition via Aquaporin 5

17. β, β-Dimethylacrylshikonin potentiates paclitaxel activity, suppresses immune evasion and triple negative breast cancer progression via STAT3Y705 phosphorylation inhibition based on network pharmacology and transcriptomics analysis

18. Stress-induced phosphoprotein 1 facilitates breast cancer cell progression and indicates poor prognosis for breast cancer patients

19. Development and validation of a novel HER2RI assay for predicting the risk of recurrence and survival in HER2-positive early breast cancer

20. PSD3 is an oncogene that promotes proliferation, migration, invasion, and G1/S transition while inhibits apoptotic in papillary thyroid cancer

21. Immortalization up‐regulated protein promotes tumorigenesis and inhibits apoptosis of papillary thyroid cancer

22. Downregulation of Immortalization-Upregulated Protein Suppresses the Progression of Breast Cancer Cell Lines by Regulating Epithelial–Mesenchymal Transition

23. KCNN4 is a diagnostic and prognostic biomarker that promotes papillary thyroid cancer progression

24. Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial

25. Clinical Analysis of BRAFV600E Mutation and Its Correlation With Sonographic Image Characteristics in Papillary Thyroid Carcinoma in Chinese Coastal Areas

26. Alpelisib Exhibits a Synergistic Effect with Pyrotinib and Reverses Acquired Pyrotinib Resistance in HER2+ Breast Cancer

27. Pan-cancer analysis of the prognostic and immunological role of PSMB8

28. Abstract GS1-08: Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for triple-negative breast cancer (cbcsg010): An open-label, randomised, multicentre, phase 3 trial

29. Downregulating integrin subunit alpha 7 (ITGA7) promotes proliferation, invasion, and migration of papillary thyroid carcinoma cells through regulating epithelial-to-mesenchymal transition

30. LINC00511 influences cellular proliferation through cyclin-dependent kinases in papillary thyroid carcinoma

31. Growth‐associated protein 43 promotes thyroid cancer cell lines progression via epithelial‐mesenchymal transition

32. Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines

33. IGSF1: A novel oncogene regulates the thyroid cancer progression

34. METTL7B promotes migration and invasion in thyroid cancer through epithelial-mesenchymal transition

35. Up-Regulated AKR1C2 is correlated with favorable prognosis in thyroid carcinoma

36. COPB2 is up‐regulated in breast cancer and plays a vital role in the metastasis via N‐cadherin and Vimentin

37. lncRNA FOXD3‐AS1 is associated with clinical progression and regulates cell migration and invasion in breast cancer

38. Pan-Cancer Analysis of the Antigen-processing Gene PSMB8 as an Immunologic and Prognostic Biomarker

39. SYT12 is a novel oncogene that promotes thyroid carcinoma progression and metastasis

40. The population characteristic analysis in RecurIndex for clinical decision-making on adjuvant therapy for early breast cancer: Results of a real-world study

41. Preoperative prediction of lymph node metastasis in patients with papillary thyroid carcinoma by an artificial intelligence algorithm

42. Phospholipase C Delta 3 inhibits apoptosis and promotes proliferation, migration, and invasion of thyroid cancer cells via Hippo pathway

43. MNX1-AS1 is a functional oncogene that induces EMT and activates the AKT/mTOR pathway and MNX1 in breast cancer

44. CLDN10 is Associated with Papillary Thyroid Cancer Progression

45. Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3

46. Prediction of central lymph node metastasis in papillary thyroid microcarcinoma according to clinicopathologic factors and thyroid nodule sonographic features: a case-control study

47. Synaptopodin-2 plays an important role in the metastasis of breast cancer via PI3K/Akt/mTOR pathway

48. Predictive Factors of Skip Metastasis in Papillary Thyroid Cancer

49. ITGA7 functions as a tumor suppressor and regulates migration and invasion in breast cancer

50. LncRNA CCND2-AS1 promotes proliferation, migration, and invasion in papillary thyroid carcinoma